Anti-inflammatory effects of moxifloxacin on IL-8, IL-1β and TNF-α secretion and NFκB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus
Open Access
- 13 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (2) , 230-235
- https://doi.org/10.1093/jac/dki441
Abstract
Objectives: We have previously shown that moxifloxacin conferred protective anti-inflammatory effects against Candida pneumonia in immunosuppressed mice. Further in vitro studies showed anti-inflammatory effects of moxifloxacin in LPS and cytokine-stimulated monocytic and epithelial cells. In the present study, concentrating on a more challenging pathogen of immunosuppressed hosts, we studied the effect of moxifloxacin on cytokine secretion and signal transduction mechanisms in monocytic cells stimulated with Aspergillus fumigatus. Methods: Human peripheral blood monocytes (PBMCs) and a human monocytic cell line (THP-1) were incubated with 1.5 × 106/mL conidia of a clinical isolate of A. fumigatus. Cytokine secretion and activation of NFκB and the MAP-kinases ERK1/2 and p38 were measured with and without the addition of moxifloxacin (5–20 mg/L). Results: Stimulation of PBMCs and THP-1 cells with A. fumigatus increased IL-8, IL-1β and TNF-α secretion (4.1-, 8.3- and 7-fold, and 5.4-, 3.7- and 17.8-fold, respectively). Addition of moxifloxacin (5–20 mg/L) inhibited cytokine secretion up to 45.7 ± 5%, 72 ± 13% and 73 ± 10% in PBMCs and up to 35.6 ± 0.5%, 30 ± 2.4% and 19 ± 4% in THP-1 cells (P < 0.05). Signal transduction studies showed that incubation of THP-1 cells with A. fumigatus increased ERK1/2 and p38 phosphorylation and p65-NFκB protein expression by 1.6-, 1.3- and 1.8-fold, respectively. Addition of moxifloxacin inhibited ERK1/2, p38 and p65-NFκB by up to 69 ± 14%, 58 ± 3% and 75 ± 15%, respectively. Conclusions: Our results indicate that moxifloxacin acts as an anti-inflammatory agent in monocytic cells stimulated withA. fumigatus conidia. Whether these effects may be protective as in the Candida pneumonia model is unknown and merits in vivo studies in models of pulmonary aspergillosis.Keywords
This publication has 21 references indexed in Scilit:
- Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal TherapyClinical Infectious Diseases, 2004
- In Vitro Activity of Caspofungin Combined with Sulfamethoxazole against Clinical Isolates of Aspergillus sppAntimicrobial Agents and Chemotherapy, 2004
- Effects of Fluoroquinolones on the Migration of Human Phagocytes through Chlamydia pneumoniae -Infected and Tumor Necrosis Factor Alpha-Stimulated Endothelial CellsAntimicrobial Agents and Chemotherapy, 2004
- Anti-Inflammatory Effects of Moxifloxacin on Activated Human Monocytic Cells: Inhibition of NF-κB and Mitogen-Activated Protein Kinase Activation and of Synthesis of Proinflammatory CytokinesAntimicrobial Agents and Chemotherapy, 2004
- Toll-like Receptor (TLR) Signaling in Response toAspergillus fumigatusJournal of Biological Chemistry, 2002
- Immunomodulatory and Protective Effects of Moxifloxacin againstCandida albicans-Induced Bronchopneumonia in Mice Injected with CyclophosphamideAntimicrobial Agents and Chemotherapy, 2002
- Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes byAspergillus fumigatusHyphaeInfection and Immunity, 2001
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- In VitroInteraction of Alveolar Macrophages andAspergillus FumigatusEnvironmental Research, 1997
- Antifungal Activity Of Elutriated Human Monocytes Against Aspergillus Fumigatus Hyphae: Enhancement By Granulocyte-Macrophage Colonystimulating Factor And Interferon-aThe Journal of Infectious Diseases, 1994